(Total Views: 453)
Posted On: 04/30/2018 11:11:05 AM
Post# of 350
Shareholder Update: Creative Medical Technology Holdings, Inc. Continues To Extinguish Debt
NEWS PROVIDED BY
Creative Medical Technology Holdings, Inc.
08:30 ET
PHOENIX, April 30, 2018 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that debt to two lenders in the amount of $163,000.00 has been retired.
As previously announced Creative Medical Technology Holdings, Inc. has taken on debt in order to advance our technologies and continue towards our goal of commercialization and cash flow.
"We continue to focus on advancing commercialization of our CaverStem™ procedure for the treatment of Erectile Dysfunction and the development of our issued patents for degenerative disc disease (StemSpine™) and our amniotic derived stem cell (AmnioStem™), as well as patents pending in the area of neurological damage due to radiation toxicity and stroke, amongst others. It is also our goal to continue to develop novel approaches to regenerative medicine which will broaden our intellectual property pipeline," said Timothy Warbington, CEO of Creative Medical Technology Holdings, Inc.
https://www.prnewswire.com/news-releases/shar...38809.html
$CELZ Looks great!
Aloha
NEWS PROVIDED BY
Creative Medical Technology Holdings, Inc.
08:30 ET
PHOENIX, April 30, 2018 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that debt to two lenders in the amount of $163,000.00 has been retired.
As previously announced Creative Medical Technology Holdings, Inc. has taken on debt in order to advance our technologies and continue towards our goal of commercialization and cash flow.
"We continue to focus on advancing commercialization of our CaverStem™ procedure for the treatment of Erectile Dysfunction and the development of our issued patents for degenerative disc disease (StemSpine™) and our amniotic derived stem cell (AmnioStem™), as well as patents pending in the area of neurological damage due to radiation toxicity and stroke, amongst others. It is also our goal to continue to develop novel approaches to regenerative medicine which will broaden our intellectual property pipeline," said Timothy Warbington, CEO of Creative Medical Technology Holdings, Inc.
https://www.prnewswire.com/news-releases/shar...38809.html
$CELZ Looks great!
Aloha
(1)
(0)
